Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 01:41
Narrative updating · score is newerSee how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
NEOGEN experienced a 46.14% gross margin, accelerating from 15.99% on 15.99%.
The company's revenue growth year-over-year declined to .7%. Its close price decreased to .1 INR, a drop from 2259.1 INR. Meanwhile, the daily volume decreased to 161,327 shares, a decline of 170,768 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 46.14 % | 15.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 15.99 % | 3.85 | ▲ |
| REVENUE_GROWTH_YOY | 34 % | 61.7 | ▼ |
| EPS_ACTUAL | 1.28 INR | 1.4 | ▼ |
| EPS_SURPRISE_PERCENT | -0.688 % | -0.482 | ▼ |
| PRICE_CHANGE_PERCENT | -1.284 % | — | - |
| DAILY_VOLUME | 1,61,327 shares | 1,70,768 | ▼ |
| CLOSE_PRICE | 2,230.1 INR | 2,259.1 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.7 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 4 count | 4 | - |
| TARGET_PRICE_PREMIUM | -1.46 % | — | - |